Skip to main content
Midas Edge

Protalix BioTherapeutics Inc

For the period ended Jun 27, 2024. Filed Apr 29, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 27, 2024 · Filed Apr 29, 2024

PLX$2.54+1.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Appendix A​

PROTALIX BIOTHERAPEUTICS, INC.

AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN, AS AMENDED

(June 27, 2024 June 28, 2023)

  1. Purposes of the Plan. The purposes of this Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company’s business.

  2. Definitions. The following definitions shall apply as used herein and in the individual Award Agreements except as defined otherwise in an individual Award Agreement. In the event a term is separately defined in an individual Award Agreement, such definition shall supercede the definition contained in this Section 2.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.